Expression and clinical significance of TRIM29, caspase-8 and β-catenin in non-small cell lung cancer

Li-jun TIAN,He YANG,Bao-feng FAN,Yu-liang ZHAO
DOI: https://doi.org/10.11877/j.issn.1672-1535.2016.14.11.23
2016-01-01
Abstract:Objective To explore the expression of TRIM29, caspase-8 andβ-catenin in non-small-cell lung cancer (NSCLC) and their clinical significance. Method Immunohistoehemical assay was used to detect the gene expression of TRIM29, caspase-8 and β-catenin in tumor tissues (NSCLC group) and adjacent normal tissues (control group) of 254 NSCLC patients, and the correlation with patient's clinicopathological features was analyzed. Result The positive ex-pression rate of TRIM29 and abnormal expression rate ofβ-catenin in NSCLC tissues were significantly higher than that in control group, but the study group had lower expression rate of caspase-8 than control group (P<0.01);TRIM29 ex-pression in lung squamous carcinoma was higher than that in lung adenocarcinoma and the abnormal expression rate ofβ-catenin was lower in lung squamous carcinoma, while the caspase-8 expression in these two tissues was of no significant difference;Survival time of patients with positive TRIM29 and caspase-8 expressions was significantly lower than that of negative patients, and survival time of patients withβ-catenin expression was significantly lower than that of low-expres-sion patients (P<0.01). Cox multi-variate analysis showed that lymph node metastasis, tumor stage, TRIM29, caspase-8 and β-catenin expression levels were independent prognostic factors influencing the survival of patients. Conclusion The expression of TRIM29, caspase-8 and β-catenin were abnormal in NSCLC, and is closely correlated with NSCLC lymph node metastasis, pathological classification, clinical stage, as well as the patients'survival time, which can be used as references for pathological classification, clinical staging and prognosis of patients with NSCLC.
What problem does this paper attempt to address?